Confocal Microscopic Analysis of the Interaction between Cisplatin and the Copper Transporter ATP7B in Human Ovarian Carcinoma Cells

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Cancer Research

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-03-0689PMID 15240550
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Short-termcis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells

  2004cited by this paper
• Cross-resistance to cisplatin in cells with acquired resistance to copper

  2004cited by this paper
• The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells.

  2003cited by this paper
• Hepatic copper metabolism: Insights from genetic disease

  2003cited by this paper
• Wilson disease protein ATP7B is localized in the late endosomes in a polarized human hepatocyte cell line.

  2003cited by this paper
• Characterization of Mouse Embryonic Cells Deficient in the Ctr1 High Affinity Copper Transporter

  2002cited by this paper
• Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper.

  2002cited by this paper
• Ultrastructural morphology and localisation of cisplatin-induced platinum-DNA adducts in a cisplatin-sensitive and -resistant human small cell lung cancer cell line using electron microscopy.

  2001cited by this paper
• Use of isogenic human cancer cells for high-throughput screening and drug discovery

  2001cited by this paper
• Copper Specifically Regulates Intracellular Phosphorylation of the Wilson's Disease Protein, a Human Copper-transporting ATPase*

  2001cited by this paper
• Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion.

  2000cited by this paper
• New insights in the cellular processing of platinum antitumor compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy

  2000cited by this paper
• Decreased accumulation of [14c]carboplatin in human cisplatin‐resistant cells results from reduced energy‐dependent uptake

  2000cited by this paper
• Copper does not alter the intracellular distribution of ATP7B, a copper-transporting ATPase.

  2000cited by this paper
• Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.

  2000cited by this paper
• Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.

  2000cited by this paper
• Hepatocyte-specific localization and copper-dependent trafficking of the Wilson's disease protein in the liver.

  1999cited by this paper
• Resistance to cisplatin.

  1999cited by this paper
• Localization of the Wilson's disease protein in human liver.

  1999cited by this paper
• Cisplatin efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8/0.7 cisplatin-resistant variant

  1999cited by this paper
• Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation.

  1998cited by this paper
• High-titer MSCV-based retrovirus generated in the pCL acute virus packaging system confers sustained gene expression in vivo.

  1998cited by this paper
• Restoration of Holoceruloplasmin Synthesis in LEC Rat after Infusion of Recombinant Adenovirus Bearing WND cDNA*

  1998cited by this paper
• Enrichment for DNA mismatch repair‐deficient cells during treatment with cisplatin

  1998cited by this paper
• Biochemical Characterization of the Wilson Disease Protein and Functional Expression in the Yeast Saccharomyces cerevisiae *

  1997cited by this paper
• Expression, Purification, and Metal Binding Properties of the N-terminal Domain from the Wilson Disease Putative Copper-transporting ATPase (ATP7B)*

  1997cited by this paper
• Two forms of Wilson disease protein produced by alternative splicing are localized in distinct cellular compartments.

  1997cited by this paper
• Mechanisms of acquired resistance to cisplatin.

  1994cited by this paper
• Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease Yamaguchi Y, Heiny ME, Gitlin JD. Biochem Biophys Res Commun 1993;197:271–277

  1994cited by this paper
• GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation.

  1994cited by this paper
• Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro.

  1994cited by this paper
• Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease.

  1993cited by this paper
• The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene

  1993cited by this paper
• Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance.

  1993cited by this paper
• Cellular accumulation of the anticancer agent cisplatin: a review.

  1993cited by this paper
• The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene

  1993cited by this paper
• Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.

  1992cited by this paper
• Role of the Na+, K(+)-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells.

  1991cited by this paper
• Role of Membrane Ion Transport in Cisplatin Accumulation

  1991cited by this paper
• Modulation of cis‐diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3‐isobutyl‐1‐methylxanthine in sensitive and resistant human ovarian carcinoma cells

  1991cited by this paper
• Characteristics of five human tumor cell lines and sublines resistant to cis‐diamminedichloroplatinum(II)

  1991cited by this paper
• Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy

  1991cited by this paper
• cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.

  1988cited by this paper
• Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.

  1987cited by this paper
• X-ray microanalysis and electron microscopy of platinum complex in the epithelium of proximal renal tubules of the cisplatin administered rabbits.

  1986cited by this paper
• X-ray microanalysis and ultrastructural localization of cisplatin in liver and kidney of the rat.

  1985cited by this paper
• Preferential nucleolar localization of Cis-DDP in human fibroblasts.

  1983cited by this paper
• Experimental ultrastructural and X-ray microanalysis study of cisplatin in the rat: intracellular localization of platinum.

  1982cited by this paper
• Cell-mediated immunity to human malignant cells. A brief review and further studies with two gynecologic tumors.

  1972cited by this paper

• A First-In-Class Broad Spectrum Inhibitor of Copper Exporting P1B-type ATPases

  2026cites this paper
• Visualizing the Invisible: Dual Click Imaging of Ruthenium-Based Photoactivated Chemotherapy Agents and Their DNA Synthesis Inhibition in Fixed Cancer Cells

  2025cites this paper
• Platinum-resistant ovarian cancer: From mechanisms to treatment strategies

  2025cites this paper
• Cisplatin Nephrotoxicity Is Critically Mediated by the Availability of BECLIN1

  2024cites this paper
• Structures of the human Wilson disease copper transporter ATP7B.

  2023cites this paper
• LINC02362/hsa-miR-18a-5p/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma.

  2023cites this paper
• Emerging roles of the copper-CTR1 axis in tumorigenesis.

  2022cites this paper
• Ovarian Cancer: Treatment and Resistance to Pharmacotherapy

  2022cites this paper
• Interference between copper transport systems and platinum drugs.

  2021cites this paper
• A BODIPY-based fluorescent sensor for the detection of Pt2+ and Pt drugs.

  2020cites this paper
• Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin

  2020cites this paper
• Mammalian copper homeostasis requires retromer-dependent recycling of the high-affinity copper transporter 1

  2020cites this paper
• Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica

  2020cites this paper
• The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer.

  2020cites this paper
• Mammalian copper homeostasis requires retromer-dependent recycling of the high-affinity copper transporter 1 (CTR1/SLC31A1)

  2020cites this paper
• Probing Liquid/Solid Interfaces at the Molecular Level

  2020cites this paper
• Synthetic lethality screening identifies FDA-approved drugs that overcome ATP7B-mediated tolerance of tumor cells to cisplatin

  2019cites this paper
• The release and detection of copper ions from ultrasmall theranostic Cu2-xSe nanoparticles.

  2019cites this paper
• Activity and Trafficking of Copper-Transporting ATPases in Tumor Development and Defense against Platinum-Based Drugs

  2019cites this paper
• Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy

  2018cites this paper
• Cisplatin-induced vestibular hair cell lesion-less damage at high doses

  2018cites this paper
• Neurotoxicity Associated with Platinum-Based Anti-Cancer Agents: What are the Implications of Copper Transporters?

  2017cites this paper
• Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cells

  2017cites this paper
• A Role for The ATP7A Copper Transporter in Tumorigenesis and Cisplatin Resistance

  2017cites this paper
• A fluorescent oxaliplatin derivative for investigation of oxaliplatin resistance using imaging techniques

  2017influential citation
• An investigation into the role of transglutaminase 2 in the uptake of cisplatin in parental and chemoresistant cancer cells

  2017cites this paper
• ATP7B expression confers multidrug resistance through drug sequestration

  2016influential citation
• The Role Of Oxidative Stress In The Establishment Of Resistance To Cisplatin In Epithelial Ovarian Cancer Cells

  2016cites this paper
• Multi-scale imaging of anticancer platinum(iv) compounds in murine tumor and kidney

  2016cites this paper
• Amphiphilic Cyanine-Platinum Conjugates as Fluorescent Nanodrugs.

  2016cites this paper
• Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs

  2015cites this paper
• Role of transporters in the distribution of platinum-based drugs

  2015cites this paper
• Mitochondria-Localized Fluorescent BODIPY-Platinum Conjugate.

  2015cites this paper
• Mechanisms of Uptake and Interaction of Platinum Based Drugs in Eukaryotic Cells

  2015cites this paper
• Confocal Fluorescence Microscopy Studies of a Fluorophore-Labeled Dirhodium Compound: Visualizing Metal–Metal Bonded Molecules in Lung Cancer (A549) Cells

  2014cites this paper
• Platinum Compounds for High‐Resolution In Vivo Cancer Imaging

  2014cites this paper
• Cisplatin handover between copper transporters: the effect of reducing agents

  2014cites this paper
• The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients

  2014cites this paper
• Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells.

  2013cites this paper
• DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells

  2013cites this paper
• ATP11B mediates platinum resistance in ovarian cancer.

  2013cites this paper
• ATP11B mediates platinum resistance in ovarian cancer.

  2013cites this paper
• Copper-transporting proteins and their interactions with platinum-based anticancer substances

  2013cites this paper
• Intestinal expression of metal transporters in Wilson’s disease

  2013cites this paper
• Determinants for Simultaneous Binding of Copper and Platinum to Human Chaperone Atox1: Hitchhiking not Hijacking

  2013cites this paper
• Interaction Between Anticancer Drug Cisplatin and Copper Chaperone Atox 1 in Human Melanoma Cells

  2013cites this paper
• Action of the anticancer drug cisplatin investigated by molecular simulation

  2013cites this paper
• Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells.

  2012cites this paper
• Membrane Transporters as Mediators of Cisplatin Effects and Side Effects

  2012cites this paper
• Probing liquid/solid interfaces at the molecular level.

  2012cites this paper
• The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin.

  2012cites this paper
• Subcellular targets of cisplatin cytotoxicity: an integrated view.

  2012cites this paper
• Structure-activity screening of platinum intercalators and molecular mechanisms for the cytotoxicity of 56MESS - [Pt(5,6-Dimethyl-Phen)(1S,2S-DACH)]²⁺

  2011cites this paper
• Bioanalytical and biophysical techniques for the elucidation of the mode of action of metal-based drugs.

  2011cites this paper
• Binding of kinetically inert metal ions to RNA: the case of platinum(II).

  2011cites this paper
• Mechanisms Involved in Ototoxicity

  2011cites this paper
• modulation of copper transporters in protection against cisplatin-induced cochlear hair cell damage

  2011cites this paper
• Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.

  2011cites this paper
• Ruolo del gene ATP7B nella resistenza al cisplatino ed ai suoi analoghi

  2011cites this paper
• ATP7B expression and trafficking in the intestine and ovary : insights into specialized function.

  2010cites this paper
• Structural organization and mechanisms of cooperativity in the N-Terminal domains of human CU-ATpases.

  2010cites this paper
• Three-dimensional models of chemotherapeutic agent transport in tumours

  2010cites this paper
• ATP7B expression is associated with in vitro sensitivity to cisplatin in non-small cell lung cancer.

  2010cites this paper
• Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs

  2010influential citation
• Roles of COMM-domain-containing 1 in stability and recruitment of the copper-transporting ATPase in a mouse hepatoma cell line.

  2010cites this paper
• Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells.

  2009cites this paper
• High Cytotoxicity of Cisplatin Nanocapsules in Ovarian Carcinoma Cells Depends on Uptake by Caveolae-Mediated Endocytosis

  2009cites this paper
• Platinum drug distribution in cancer cells and tumors.

  2009cites this paper
• Novel strategies for reversing platinum resistance.

  2009cites this paper
• Therapeutic Targeting of ATP7B in Ovarian Carcinoma

  2009cites this paper
• Altered Localization of Transport Proteins Associated with Cisplatin Resistance

  2009influential citation
• Regulation of the Export of Platinum-Containing Drugs by the Copper Efflux Transporters ATP7A and ATP7B

  2009cites this paper
• Effects of the loss of Atox1 on the cellular pharmacology of cisplatin.

  2009cites this paper
• Copper Transporter 2 (CTR2) as a regulator of cisplatin accumulation and sensitivity - eScholarship

  2009cites this paper
• Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design

  2009cites this paper
• Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas

  2009cites this paper
• Human copper transporters: mechanism, role in human diseases and therapeutic potential.

  2009cites this paper
• Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin‐based chemotherapy

  2009cites this paper
• Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer model.

  2009cites this paper
• Cancer Therapy: Preclinical Therapeutic Targeting of ATP7B in Ovarian Carcinoma

  2009cites this paper
• Functional Interactions of Cu-ATPase ATP7B with Cisplatin and the Role of ATP7B in the Resistance of Cells to the Drug*

  2009cites this paper
• Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.

  2008cites this paper
• The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy.

  2008cites this paper
• Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells

  2008influential citation
• Transport of Cisplatin by the Copper Efflux Transporter ATP7B

  2008influential citation
• Copper transport systems are involved in multidrug resistance and drug transport.

  2008cites this paper
• Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.

  2008cites this paper
• Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer

  2008cites this paper
• Characterization of the role of copper transporting ATPase, ATP7B (Wilsons disease protein), in copper homeostasis.

  2008cites this paper
• Copper Metabolism and Copper Transport Disorders

  2007cites this paper
• Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model

  2007cites this paper
• Function and regulation of human copper-transporting ATPases.

  2007cites this paper
• Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters

  2006cites this paper
• Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin

  2006cites this paper
• Chemical microscopy applied to biological systems.

  2006cites this paper
• High effectiveness of platinum complexes with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro PhD Thesis

  2006cites this paper
• Activation of carboplatin by carbonate.

  2006cites this paper
• Role of copper transporters in the uptake and efflux of platinum containing drugs.

  2006cites this paper
• Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance.

  2005cites this paper
• Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells

  2005cites this paper